A cardiologist’s recent post on Instagram is racking up tons of views and comments for its major revelation about heart ...

Following priority review, the FDA approved Kerendia for the treatment of patients with heart failure with left ventricular ejection fraction (LVEF) ≥40%.

The FDA expanded the indication for finerenone (Kerendia) in heart failure (HF), drug manufacturer Bayer announced.

Micah Clayborne was diagnosed with Danon disease, a rare condition, after complaining of chest pains. He needed a heart ...

Heart failure, a leading cause of death in the US, can be triggered by cardiac amyloidosis, a condition often misdiagnosed as ...

Wearables and telehealth are teaming up to transform chronic care. This connected model offers real-time data for proactive, ...

Heart failure, a condition where the heart doesn't pump blood efficiently, manifests through symptoms like shortness of ...

Following priority review, the U.S. Food and Drug Administration approved Bayer's Kerendia (finerenone) for the treatment of ...

One arm is more likely that the other to hurt during a heart attack. It's the arm that shares nerves that branch from the ...

Discover how MemorialCare's Women's Heart Center at Long Beach is tackling the leading killer of women, heart disease, ...

Piedmont has expanded access to outpatient heart failure management with a new heart failure clinic at Piedmont Newton ...

A common habit may be increasing your risk of heart disease, heart failure and stroke, a study suggests. Researchers found ...